IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Portfolio Profile

CIK: 0001397144 | London, X0

$306.9M
AUM
19
Positions
96.9%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Vaxcyte Inc(PCVX)2,019,057$96.8M31.54%
2Verona Pharma PLC(VRNA)2,457,500$64.2M20.92%
3Vera Therapeutics Inc(VERA)2,960,231$57.3M18.66%
4Hillevax Inc1,838,486$30.8M10.02%
5Adicet BIO Inc(TORCEUR)2,115,385$18.9M6.16%
6Phathom Pharmaceuticals Inc(PHAT)1,435,106$16.1M5.25%
7Reneo Pharmaceuticals Inc(RPHM)2,073,957$4.8M1.57%
8Sientra Inc1,673,589$3.4M1.11%
9Jasper Therapeutics Inc5,628,558$2.7M0.89%
10Soleno Therapeutics Inc(SLNO)1,201,506$2.4M0.78%

Sector Allocation

Latest filing, equity positions only

Healthcare56.23% · $172.6M
Unclassified43.77% · $134.3M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare61.9%56.23%-5.67%
Unclassified38.1%43.77%+5.67%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$150.6K | 16 pos.
$357.7K | 16 pos.
$467.5K | 17 pos.
$292.3K | 15 pos.
$289.6K | 17 pos.
$323.5K | 19 pos.
Cap SizePrev %Curr %Change
Mid Cap55.78%50.21%-5.57%
Unclassified38.1%43.77%+5.67%
Small Cap6.12%6.02%-0.1%
$440.7K | 20 pos.
$412.7K | 20 pos.
$352.5K | 20 pos.
$312.4K | 21 pos.
$292.5K | 19 pos.
$306.9M | 19 pos.
Q1
20
Q2
20
Q3
20
Q4
20
Q1
21
Q2
21
Q3
21
Q4
21
Q1
22
Q2
22
Q3
22
Q4
22

Recent Activity

Quarter-over-quarter position changes

0
New
0
Closed
0
Increased
1
Decreased
18
Unchanged